Cardiac Outcomes after Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance without Diabetes

BACKGROUND: Insulin resistance is highly prevalent among patients with atherosclerosis and is associated with an increased risk for myocardial infarction (MI) and stroke. The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone decreased the composite risk for fat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Circulation
Main Authors: Young, Lawrence H., Viscoli, Catherine M., Curtis, Jeptha P., Inzucchi, Silvio E., Schwartz, Gregory G., Lovejoy, Anne M., Furie, Karen L., Gorman, Mark J., Conwit, Robin, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Pfau, Steven E., Ling, Frederick S., Kernan, Walter N.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511545/
https://ncbi.nlm.nih.gov/pubmed/28246237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.116.024863
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki